{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:20:58Z","timestamp":1769757658841,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pnpbp.2025.111465","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T21:51:52Z","timestamp":1754862712000},"page":"111465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Enhancing addiction care: Benefits of urinary screening with LC-HRMS (liquid chromatography-high resolution mass spectrometry) for psychoactive substances and drugs"],"prefix":"10.1016","volume":"141","author":[{"given":"Edouard","family":"Le Carpentier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Helesbeux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Biering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Aquizerate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Rousselet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Barrangou-Poueys-Darlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Verholleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dailly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Victorri-Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111465_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/biology11050645","article-title":"New psychoactive substances consumption in opioid-use disorder patients","volume":"11","author":"Al\u00edas-Ferri","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0010","article-title":"A systematic review of the cardiotoxicity of methadone","author":"Alinejad","year":"2015","journal-title":"EXCLI J."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/17512433.2023.2211261","article-title":"Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS","volume":"16","author":"Battini","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0020","series-title":"Advances in Clinical Chemistry","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.acc.2022.08.001","article-title":"Drug testing in the era of new psychoactive substances","volume":"111","author":"Gerona","year":"2022"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0025","first-page":"12","article-title":"Accr\u00e9ditation du criblage toxicologique: recommandations du groupe SFBC \u2014 SFTA","volume":"31","author":"Guitton","year":"2019","journal-title":"Toxicol. Anal. Clin."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hup.2512","article-title":"New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening: polydrug abuse in opioid maintenance treatment","volume":"31","author":"Heikman","year":"2016","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.aca.2015.08.018","article-title":"Orbitrap technology for comprehensive metabolite-based liquid chromatographic\u2013high resolution-tandem mass spectrometric urine drug screening \u2013 exemplified for cardiovascular drugs","volume":"891","author":"Helfer","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/FTD.0000000000001163","article-title":"Comprehensive monitoring of psychoactive substances in psychiatric patients using liquid chromatography\u2013high-resolution mass spectrometry: a key tool for treatment planning and understanding consumption patterns in Rome, Italy","volume":"46","author":"La Maida","year":"2024","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/MEJ.0000000000000310","article-title":"SODAS: surveillance of drugs of abuse study","volume":"24","author":"Lowe","year":"2017","journal-title":"Eur. J. Emerg. Med."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084000","article-title":"Ultra-high performance liquid chromatography-high resolution mass spectrometry and high-sensitivity gas chromatography-mass spectrometry screening of classic drugs and new psychoactive substances and metabolites in urine of consumers","volume":"22","author":"Marchei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106649","article-title":"Comparison of several immunoassays used in drugs of abuse screening: assessment against gold standard methods and calculation of measurement uncertainty","volume":"101","author":"Mina","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0060","doi-asserted-by":"crossref","DOI":"10.24425\/fmc.2023.145917","article-title":"Guilty or not guilty? \u2014 false positive results of common medicines in drug tests: review and practical guide","author":"Mo\u017cd\u017ce\u0144","year":"2023","journal-title":"Folia Med. Cracov."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0065","first-page":"536","article-title":"The cocaine cutting agent levamisole is frequently detected in cocaine users","volume":"50","author":"Pope","year":"2018","journal-title":"Pathology (Phila.)"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jat\/bkac089","article-title":"False-positive amphetamines in urine drug screens: a 6-year review","volume":"47","author":"Pope","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010112","article-title":"Comparison of two immunoassay screening methods and a LC-MS\/MS in detecting traditional and designer benzodiazepines in urine","volume":"27","author":"Rossi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jat\/bku075","article-title":"False-positive interferences of common urine drug screen immunoassays: a review","volume":"38","author":"Saitman","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0085","unstructured":"Sant\u00e9 Publique France. Tableau des dur\u00e9es de positivit\u00e9."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/FSMP:2:2:75","article-title":"Immunoassays for drug screening in urine: chances, challenges, and pitfalls","volume":"2","author":"Sch\u00fctz","year":"2006","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/dta.1683","article-title":"Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry in post-mortem urine","volume":"7","author":"Sundstr\u00f6m","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/dta.1818","article-title":"Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS","volume":"8","author":"Sundstr\u00f6m","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jmsacl.2024.06.002","article-title":"Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations","volume":"33","author":"Tolan","year":"2024","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/15563650.2022.2131566","article-title":"Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis","volume":"61","author":"Virmani","year":"2023","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.pnpbp.2025.111465_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40268-021-00375-y","article-title":"Pharmacokinetics of diazepam and its metabolites in urine of Chinese participants","volume":"22","author":"Wang","year":"2022","journal-title":"Drugs RD"},{"key":"10.1016\/j.pnpbp.2025.111465_bb0120","author":"Woosley"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:28:53Z","timestamp":1765913333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625002192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"alternative-id":["S0278584625002192"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111465","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing addiction care: Benefits of urinary screening with LC-HRMS (liquid chromatography-high resolution mass spectrometry) for psychoactive substances and drugs","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111465"}}